Thursday, October 31, 2024

Q/A or Two

Dedicated to: The Late, Great Dr. & Mrs. Garlington

By Jeremy C. Garlington

So, here's a question or two on my current terminal health state called Glioblastoma: Is the disease forever going to be terminal? How long will I live after diagnosis?

Sorry, but starting with questions that way remain less preferred by those with terminal diseases. While most of us love or appreciate inquiries via concern, here's another way to ask/answer the same line of query if you're interested. (Btw: This same style or approach can be used in other situations, too. Such as...)

"I'm sorry to hear; that's gotta be tough..." When diagnosed or treated for Glioblastoma, the best condition you can have is neutral. That generally means you're not positive or negative, which in normal terms, might be ambitious. It’s actually quasi-positive. No active disease = no road (yet) to death. Glioblastoma is terminal. At least until a cure emerges, which hasn't yet.

From there, defining situation or condition can take a somewhat positive turn...

"I'm currently in Year Three. Doing well with very little if any side effects. Only strange action is taking 12-15 pills 💊 per day."

Only five to seven percent of victims live this long, which places things in rare, advanced position. Everything related should put new meaning into the saying "every day is a new day."

Here's my fave, from the old PIKERS, a VA. founded fraternity:

"Yesterday is gone forever, and tomorrow is yet to be...(New insert) Yet the current can be total...harmony."

Good day,

JG/Jeremy Garlington/404-606-0637


No comments:

First of its kind

"The Garlington Report" (TGR) represents the first new media forum devoted exclusively to executive-level leadership from the talent and search points of view.

For regular readers, rest assured -- you will continue to find monthly Pointes and other content that you've grown accustomed to. Please also feel free to navigate back to the consultancy's URL at http://www.pointofviewllc.com/.

Thanks for continuing to read, JG